A new approach to the analysis of analgesic drug trials, illustrated with bromfenac data.
about
Pharmacodynamic models for discrete data.The back-step method--method for obtaining unbiased population parameter estimates for ordered categorical dataImplementation and evaluation of the SAEM algorithm for longitudinal ordered categorical data with an illustration in pharmacokinetics-pharmacodynamicsInformative dropout modeling of longitudinal ordered categorical data and model validation: application to exposure-response modeling of physician's global assessment score for ustekinumab in patients with psoriasis.Pharmacodynamic differentiation of lorazepam sleepiness and dizziness using an ordered categorical measureModelling of pain intensity and informative dropout in a dental pain model after naproxcinod, naproxen and placebo administration.Simultaneous Exposure-Response Modeling of ACR20, ACR50, and ACR70 Improvement Scores in Rheumatoid Arthritis Patients Treated With Certolizumab Pegol.Expanding clinical applications of population pharmacodynamic modelling.Population pharmacokinetics of clomethiazole and its effect on the natural course of sedation in acute stroke patients.Pharmacokinetic/pharmacodynamic models for the depletion of Vbeta5.2/5.3 T cells by the monoclonal antibody ATM-027 in patients with multiple sclerosis, as measured by FACSResearch designs for proof-of-concept chronic pain clinical trials: IMMPACT recommendationsPopulation analyses of efficacy and safety of ABT-594 in subjects with diabetic peripheral neuropathic pain.Relation between acute and long-term cognitive decline after surgery: Influence of metabolic syndrome.Non-linear mixed effects modeling - from methodology and software development to driving implementation in drug development science.Approaches to simultaneous analysis of frequency and severity of symptoms.Pharmacokinetic-pharmacodynamic modeling in acute and chronic pain: an overview of the recent literature.Translational PK-PD modeling in pain.Disease progression and neuroscience.Considerations when using pharmacokinetic/pharmacodynamic modeling to determine the effectiveness of simple analgesics in children.Pharmacodynamic analysis of analgesic clinical trials: nonlinear mixed-effects logistic models.Postoperative analgesia using diclofenac and acetaminophen in children.Evaluation of tests of central nervous system performance after hypoxemia for a model for cognitive impairment.Biostatistics and pharmacometrics: quantitative sciences to propel drug development forward.Population pharmacokinetics in veterinary medicine: potential use for therapeutic drug monitoring and prediction of tissue residues.Extending the latent variable model for extra correlated longitudinal dichotomous responses.The impact of clonidine on sedation after adenotonsillectomy: a prospective audit.Modeling of in vitro drug activity and prediction of clinical outcome in acute myeloid leukemia.Modeling Composite Assessment Data Using Item Response Theory.
P2860
Q30578472-55D2A252-1F57-4F70-A788-CFD5C162725DQ33212737-5BEDF5E9-5486-44AB-A981-883DC198DE8FQ33743151-C638A6F6-A84D-4585-BD97-18E14B80A5D1Q33822458-96577BA1-8704-4516-8380-FA40C2274DC6Q34055606-6623E359-0013-4791-BEBD-A7818FC3C9E7Q34996927-196C3F71-01C8-4027-9A74-13921B97A564Q35760130-B5D6710B-2A15-4EA2-A17E-687E0FB42DB1Q35803310-DAEFFDFE-BDC1-48F4-89EF-1D1794DC1B41Q35825504-E31A2C69-1054-4881-945B-AFA26E879A4AQ35826428-3385CDA6-57C2-4FC9-8B85-7948B15B4535Q35846608-3497DB29-82FE-4A77-AD5E-AAB744B8C408Q35888354-9A159FBA-66FE-42F4-B1AD-4CF4C339311EQ36244956-210682DE-7DDC-4018-943E-8D2B13DBDEFAQ36311608-5B260F28-0C3B-4C6F-AF49-EA482EC0B46CQ37770956-02289A1A-32EB-4C50-B2EB-B6F93F55DE08Q37960128-CBEDA5E5-D14B-40E7-BA78-68605BA6EC4AQ38063813-E98F4866-4CD4-4D6F-B6E8-D56544A17545Q38099584-00FE40FC-4428-41B9-A2B6-B8DECBD54CEDQ38544082-81AFAC70-36E0-4064-8282-E0A25FDD705BQ39438277-C584EF20-CC5C-45F7-AA84-D8B77E5A0C88Q44066008-21774FB8-22ED-4195-B462-8230A8FC5C31Q44263541-3CDF4DBA-98FC-4D81-AD1F-311EE914F934Q44584249-FCF92271-9831-40E5-B48B-61A8E840E6C8Q44869875-53DCB7D9-F5B0-4FA9-97E5-32AB817943D8Q46443885-4D804EA1-AF4E-4859-ADAB-5A5C68A75F17Q47853704-D4C16A12-1677-4CFA-A291-47E7DE9F1A0FQ51909505-5AD6F8CA-ADE1-4D32-B5CA-C37614BD5497Q55276388-DDCEDACD-7009-47D5-8A70-A8D4AC414CF7
P2860
A new approach to the analysis of analgesic drug trials, illustrated with bromfenac data.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
A new approach to the analysis of analgesic drug trials, illustrated with bromfenac data.
@ast
A new approach to the analysis of analgesic drug trials, illustrated with bromfenac data.
@en
type
label
A new approach to the analysis of analgesic drug trials, illustrated with bromfenac data.
@ast
A new approach to the analysis of analgesic drug trials, illustrated with bromfenac data.
@en
prefLabel
A new approach to the analysis of analgesic drug trials, illustrated with bromfenac data.
@ast
A new approach to the analysis of analgesic drug trials, illustrated with bromfenac data.
@en
P356
P1476
A new approach to the analysis of analgesic drug trials, illustrated with bromfenac data.
@en
P2093
Sheiner LB
P304
P356
10.1038/CLPT.1994.142
P407
P577
1994-09-01T00:00:00Z